Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine in Idiopathic Restless Leg Syndrome
NCT00136045Phase 3Completed
- Sponsor
- UCB
- Start
- May 2005
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rotigotine in restless legs syndrome (RLS), sponsored by UCB. Started May 2005; status: completed.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00136045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136045.